HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chenhui Li Selected Research

nafamostat

1/2017Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats.
8/2016Nafamostat mesilate improves function recovery after stroke by inhibiting neuroinflammation in rats.
1/2016Nafamostat mesilate protects against acute cerebral ischemia via blood-brain barrier protection.
7/2014Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chenhui Li Research Topics

Disease

9Inflammation (Inflammations)
04/2024 - 11/2015
8Neoplasms (Cancer)
04/2024 - 01/2021
5Ischemic Stroke
04/2024 - 07/2014
4Neuroinflammatory Diseases
04/2024 - 11/2015
4Bites and Stings (Sting)
04/2024 - 01/2021
4Hearing Loss (Hearing Impairment)
05/2021 - 01/2019
2Rectal Neoplasms (Rectal Cancer)
03/2024 - 05/2022
2Weight Gain
01/2024 - 01/2022
2Autoimmune Diseases (Autoimmune Disease)
09/2022 - 01/2021
2Colitis
08/2022 - 07/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 01/2022
2Infections
01/2022 - 01/2021
2Fibrosis (Cirrhosis)
01/2021 - 01/2021
2Alzheimer Disease (Alzheimer's Disease)
07/2018 - 03/2016
2Ulcerative Colitis
01/2017 - 07/2016
2Stroke (Strokes)
01/2017 - 08/2016
2Brain Infarction
01/2016 - 07/2014
2Brain Ischemia (Cerebral Ischemia)
01/2016 - 07/2014
1Stomach Neoplasms (Stomach Cancer)
04/2024
1Lung Neoplasms (Lung Cancer)
12/2023
1Colonic Neoplasms (Colon Cancer)
12/2023
1Colorectal Neoplasms (Colorectal Cancer)
05/2023
1Weight Loss (Weight Reduction)
05/2023
1Dental Caries (Decay, Dental)
05/2023
1Dental Plaque
05/2023
1Liver Neoplasms (Liver Cancer)
03/2023
1Fatty Liver
01/2023
1Insulin Resistance
01/2023
1Melanoma (Melanoma, Malignant)
09/2022
1Neuroacanthocytosis
09/2022
1COVID-19
08/2022
1Dysbiosis
08/2022
1Adenocarcinoma of Lung
01/2022
1Rheumatoid Arthritis
01/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Tracheal Stenosis
01/2022

Drug/Important Bio-Agent (IBA)

5DNA (Deoxyribonucleic Acid)IBA
04/2024 - 01/2021
4Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2020
4Proteins (Proteins, Gene)FDA Link
09/2023 - 01/2019
4Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2017 - 07/2014
4nafamostatIBA
01/2017 - 07/2014
3MicroRNAs (MicroRNA)IBA
04/2024 - 01/2023
3CytokinesIBA
12/2023 - 11/2015
3Glucose (Dextrose)FDA LinkGeneric
01/2016 - 03/2015
3Oxygen (Dioxygen)IBA
01/2016 - 03/2015
2cyclic guanosine monophosphate-adenosine monophosphateIBA
04/2024 - 01/2021
2InterferonsIBA
04/2024 - 01/2021
2Long Noncoding RNAIBA
04/2024 - 01/2022
2IronIBA
01/2023 - 01/2021
2Interferon Type IIBA
01/2022 - 01/2021
2Antiviral Agents (Antivirals)IBA
01/2022 - 01/2021
2AntioxidantsIBA
01/2022 - 04/2021
2Amyloid (Amyloid Fibrils)IBA
07/2018 - 03/2016
2Serine Proteases (Serine Protease)IBA
01/2016 - 07/2014
2ThrombinFDA Link
01/2016 - 07/2014
2Glutamic Acid (Glutamate)FDA Link
10/2015 - 03/2015
1Tissue Plasminogen Activator (Alteplase)FDA Link
04/2024
1Neuroprotective AgentsIBA
04/2024
1Indicators and Reagents (Reagents)IBA
03/2024
1LipidsIBA
01/2024
1Immune Checkpoint InhibitorsIBA
12/2023
1MethyltransferasesIBA
12/2023
1CarbohydratesIBA
09/2023
1ThymalfasinIBA
05/2023
1N-hydroxy-2-aminopyreneIBA
05/2023
1Durapatite (Hydroxylapatite)IBA
05/2023
1Starch (Cornstarch)IBA
01/2023
1Insulin (Novolin)FDA Link
01/2023
1SaponinsIBA
01/2023
1Messenger RNA (mRNA)IBA
01/2023
1Interleukin-2 (IL2)IBA
09/2022
1NivolumabIBA
09/2022
1bempegaldesleukinIBA
09/2022
1Volatile Fatty AcidsIBA
08/2022
1WastewaterIBA
08/2022
11- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA
06/2022
1VimentinIBA
05/2022
1Cadherins (E-Cadherin)IBA
05/2022
1Phosphotransferases (Kinase)IBA
01/2022
1olaparibIBA
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1AmylasesFDA Link
01/2022
1CarbonatesIBA
01/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2022
1Lipase (Acid Lipase)FDA Link
01/2022
1lorlatinibIBA
01/2022
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022
1Antirheumatic Agents (DMARD)IBA
01/2022
1Hexachlorocyclohexane (gamma-Hexachlorocyclohexane)FDA LinkGeneric
05/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
05/2021
1Oxidants (Oxidizing Agents)IBA
04/2021
1Vehicle Emissions (Emissions, Vehicle)IBA
04/2021

Therapy/Procedure

7Therapeutics
04/2024 - 01/2016
1Neoadjuvant Therapy
03/2024
1Artificial Tooth (Artificial Teeth)
05/2023
1Euthanasia (Mercy Killing)
03/2023
1Immunotherapy
09/2022
1Oral Administration
08/2022
1Drug Therapy (Chemotherapy)
01/2022